Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neurocritical and Neurohospitalist Care

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1598156

Stroke-associated pneumonia with low PaO2/FiO2 ratio in acute large vessel occlusion after endovascular therapy: Risk factors and prognosis

Provisionally accepted
Kun  TangKun Tang1Jia  LiJia Li1Yucheng  WangYucheng Wang1Zhangbao  GuoZhangbao Guo1Yun  YangYun Yang1Fangliang  GuoFangliang Guo1Yin  CaiYin Cai2Wenhua  LiuWenhua Liu1*
  • 1Department of Neurology, Wuhan No. 1 Hospital, Wuhan, China
  • 2Hong Kong Polytechnic University, Kowloon, Hong Kong, SAR China

The final, formatted version of the article will be published soon.

Background: Stroke-associated pneumonia (SAP) often occurs after ischemic stroke. A deterioration in SAP manifests itself in a decreased partial pressure oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio, indicating gas exchange dysfunction. We aimed to investigate independent predictors and outcomes of SAP with low PaO2/FiO2 ratio among patients with acute large vessel occlusion (ALVO) undergoing endovascular therapy. Methods: We retrospectively analyzed the prospective data of consecutive adult post-interventional patients with ALVO admitted to neuro-intensive care units in Wuhan No. 1 Hospital from December 2020 to December 2022. Patients developing SAP without coronavirus disease 2019 were included in this study and divided into two subgroups: PaO2/FiO2 ratio >240 and ≤240. The primary outcome was favorable neuro-function at 90 days (modified Rankin Scale score of 0-2). Secondary outcomes included hospitalization days, occurrence of symptomatic intracerebral hemorrhage, and 90-day mortality. The independent risk factors and prognosis for SAP with PaO2/FiO2 ratio ≤240 were identified by logistic regression analyses. Results: A total of 159 subjects developing SAP were included in this study: 53 with PaO2/FiO2 ratio >240 and 106 with ratio ≤240. Compared to subjects with PaO2/FiO2 ratio >240, those with PaO2/FiO2 ratio ≤240 had older ages, higher baseline National Institutes of Health Stroke Scales scores, larger proportions of baseline Glasgow Coma Scale (GCS) score of 3-8 and grade of kobuta water swallow test ≥3, higher white blood cell (WBC) counts (all p values <0.05). The independent predictors for SAP with PaO2/FiO2 ratio ≤240 included ages (adjusted odds ratio [OR], 1.043; 95% confidential interval [CI], 1.011-1.077; p=0.009), baseline GCS scores of 3-8 (adjusted OR, 2.802; 95% CI, 1.214-6.465; p=0.016), and ln-transformed WBC counts after SAP diagnosis (adjusted OR, 3.977; 95% CI, 1.226-12.896; p=0.021). SAP with PaO2/FiO2 ratio ≤240 was robustly associated with longer hospitalization days (adjusted OR, 1.074; 95% CI, 1.01-1.143; p=0.024). Conclusions: SAP with PaO2/FiO2 ratio ≤240 is shown in significant relevance to the prolonged in-hospital stays among post-interventional patients. Older ages, baseline GCS scores of 3-8, and higher WBC counts after SAP diagnosis can independently predict the occurrence of SAP with a lower PaO2/FiO2 ratio. Further validation studies are needed.

Keywords: Stroke-associated pneumonia, PaO2/FIO2 ratio, ischemic stroke, Endovascular Therapy, risk factor, prognosis

Received: 23 Apr 2025; Accepted: 21 Jul 2025.

Copyright: © 2025 Tang, Li, Wang, Guo, Yang, Guo, Cai and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Wenhua Liu, Department of Neurology, Wuhan No. 1 Hospital, Wuhan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.